Immuno-nanocarriers for brain delivery: limitations from in vitro to preclinical and clinical studies

Joana A Loureiro; Maria João Ramalho; Maria do Carmo Pereira

doi:10.2217/nnm-2019-0402

Immuno-nanocarriers for brain delivery: limitations from in vitro to preclinical and clinical studies

Nanomedicine (Lond). 2020 Mar;15(6):543-545. doi: 10.2217/nnm-2019-0402. Epub 2020 Feb 14.

Authors

Joana A Loureiro¹, Maria João Ramalho¹, Maria do Carmo Pereira¹

Affiliation

¹ LEPABE - Laboratory for Process Engineering, Environment, Biotechnology & Energy, Faculty of Engineering, University of Porto, Rua Dr Roberto Frias, 4200-465, Porto, Portugal.

PMID: 32056491
DOI: 10.2217/nnm-2019-0402

No abstract available

Keywords: Alzheimer's disease; PLGA nanoparticles; Parkinson's disease; antibodies; blood–brain barrier; brain cancer; drug targeting; liposomes; nanoparticles; neurological diseases; solid lipid nanoparticles.

Publication types

Editorial

MeSH terms

Animals
Blood-Brain Barrier
Brain*
Drug Delivery Systems*
Humans
Nanoparticles*